This is in discrepancy with a published study, reporting LBH is downregulated in PRAD (based on a limited number of clinical samples), and to have tumor suppressive effects when overexpressed as LBH-GFP fusion protein in PC3M cells [48]. Here, LBH is linked to prostate adenocarcinoma.